Results 141 to 150 of about 1,741 (166)

Allergic bronchopulmonary aspergillosis successfully treated with tezepelumab

The Journal of Allergy and Clinical Immunology: In Practice, 2023
openaire   +2 more sources

Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study

Clinical and Experimental Allergy, 2023
Jonathan Corren, Jean-Pierre Llanos
exaly  

An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma

Expert Opinion on Drug Discovery, 2023
Paola Rogliani, Josuél Ora, Maria Gabriella Matera   +2 more
exaly  

Effects of Tezepelumab on Quality of Life of Patients with Moderate-to-Severe, Uncontrolled Asthma: Systematic Review and Meta-Analysis

Current Allergy and Asthma Reports, 2023
Gabriel Chagas
exaly  

NAVIGATOR steers asthma patients to tezepelumab

Medicom Conference Report ATS 2022, 2022
Njira Lugogo, Rachel Giles
openaire   +1 more source

Tezepelumab in active osteoarthritis with asthma

Journal of Allergy and Clinical Immunology
Roberto Colli, Jakob Nilsson, Lukas Frischknecht   +2 more
openaire   +2 more sources

SEVERE EGPA – A ROLE FOR TEZEPELUMAB?

Annals of Allergy, Asthma & Immunology
R. Crawford, M. Sullivan, J. Azar, C. Costello, C. Freeman   +4 more
openaire   +1 more source

Dupilumab/Tezepelumab

Reactions Weekly
openaire   +1 more source

Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma

Expert Opinion on Investigational Drugs, 2019
Giuseppe Spadaro, Mariantonia Braile, Remo Poto   +2 more
exaly  

Omalizumab/tezepelumab

Reactions Weekly
openaire   +1 more source